scholarly article | Q13442814 |
P356 | DOI | 10.1111/FEBS.14056 |
P698 | PubMed publication ID | 28294537 |
P2093 | author name string | Kyle K Biggar | |
Zhouran Wu | |||
Justin Connolly | |||
P2860 | cites work | Identification of arginine- and lysine-methylation in the proteome of Saccharomyces cerevisiae and its functional implications | Q21267196 |
Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes | Q21562301 | ||
p53 is regulated by the lysine demethylase LSD1 | Q24292925 | ||
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells | Q24293124 | ||
G9a and Glp methylate lysine 373 in the tumor suppressor p53 | Q24298004 | ||
Methylation of the retinoblastoma tumor suppressor by SMYD2 | Q24300912 | ||
L3MBTL1, a histone-methylation-dependent chromatin lock | Q24307503 | ||
Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein | Q24310370 | ||
Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling | Q24312041 | ||
Identification and characterization of a novel human methyltransferase modulating Hsp70 protein function through lysine methylation | Q24315705 | ||
Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation | Q36381487 | ||
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia | Q36515569 | ||
SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence. | Q36582281 | ||
Role for 53BP1 Tudor domain recognition of p53 dimethylated at lysine 382 in DNA damage signaling | Q37000240 | ||
Large-scale global identification of protein lysine methylation in vivo | Q37089501 | ||
Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation | Q37256023 | ||
Global proteomic analysis in trypanosomes reveals unique proteins and conserved cellular processes impacted by arginine methylation | Q37605010 | ||
Lysine methylation: beyond histones | Q37970950 | ||
Push back to respond better: regulatory inhibition of the DNA double-strand break response | Q38133962 | ||
An H3K9/S10 methyl-phospho switch modulates Polycomb and Pol II binding at repressed genes during differentiation | Q38266057 | ||
Non-histone protein methylation as a regulator of cellular signalling and function | Q38285792 | ||
Critical roles of non-histone protein lysine methylation in human tumorigenesis | Q38329400 | ||
Identification and characterization of lysine-methylated sites on histones and non-histone proteins | Q38479488 | ||
Emerging roles of lysine methylation on non-histone proteins | Q38557842 | ||
Protein lysine methylation by seven-β-strand methyltransferases | Q38894639 | ||
Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma | Q39021479 | ||
Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis | Q39147711 | ||
Regulation of the androgen receptor by SET9-mediated methylation | Q39642231 | ||
Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo | Q40012428 | ||
The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. | Q40050639 | ||
Concerted activities of distinct H4K20 methyltransferases at DNA double-strand breaks regulate 53BP1 nucleation and NHEJ-directed repair | Q42793535 | ||
A proteomic analysis of arginine-methylated protein complexes | Q44611061 | ||
The cation-π interaction at protein-protein interaction interfaces: developing and learning from synthetic mimics of proteins that bind methylated lysines | Q45777054 | ||
Control of the hippo pathway by Set7-dependent methylation of Yap. | Q46240754 | ||
Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis | Q46722069 | ||
p53-dependent transcription and tumor suppression are not affected in Set7/9-deficient mice. | Q53224748 | ||
Specificity Analysis-Based Identification of New Methylation Targets of the SET7/9 Protein Lysine Methyltransferase | Q57267611 | ||
ɛ-N-Methyl-lysine in Bacterial Flagellar Protein | Q59051870 | ||
Repression of p53 activity by Smyd2-mediated methylation | Q24315991 | ||
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 | Q24336747 | ||
Modulation of p53 function by SET8-mediated methylation at lysine 382 | Q24337822 | ||
PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53 | Q24594648 | ||
Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair | Q24669691 | ||
Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry | Q24805791 | ||
Structural Basis for Lower Lysine Methylation State-Specific Readout by MBT Repeats of L3MBTL1 and an Engineered PHD Finger | Q27649150 | ||
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 | Q27653816 | ||
The MBT Repeats of L3MBTL1 Link SET8-mediated p53 Methylation at Lysine 382 to Target Gene Repression | Q27664677 | ||
Structural basis of substrate methylation and inhibition of SMYD2 | Q27670959 | ||
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain | Q27860477 | ||
Regulation of histone methylation by demethylimination and demethylation | Q28291841 | ||
The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains | Q29614228 | ||
The diverse functions of histone lysine methylation | Q29614523 | ||
Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation | Q29614524 | ||
Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage | Q29614528 | ||
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations | Q29615392 | ||
Histone methylation in transcriptional control | Q29616553 | ||
Epigenetic protein families: a new frontier for drug discovery | Q29616621 | ||
VEGF receptor signalling - in control of vascular function | Q29617256 | ||
trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. | Q33279148 | ||
A method for systematic mapping of protein lysine methylation identifies functions for HP1β in DNA damage response | Q33656610 | ||
The nuclear factor NF-kappaB pathway in inflammation | Q34114512 | ||
EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex | Q34305930 | ||
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer | Q34420873 | ||
Regulation of p53 function by lysine methylation | Q35149921 | ||
Discovery of substrates for a SET domain lysine methyltransferase predicted by multistate computational protein design. | Q35532661 | ||
Histone lysine methylation: a signature for chromatin function | Q35571556 | ||
A Proteomic Strategy Identifies Lysine Methylation of Splicing Factor snRNP70 by the SETMAR Enzyme | Q35583081 | ||
Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties | Q35587244 | ||
Bioorthogonal profiling of protein methylation using azido derivative of S-adenosyl-L-methionine | Q35912065 | ||
RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation | Q36088167 | ||
Involvement of E2F transcription factor family in cancer | Q36280634 | ||
Proteome-wide enrichment of proteins modified by lysine methylation. | Q36294652 | ||
P407 | language of work or name | English | Q1860 |
P577 | publication date | 2017-03-09 | |
P1433 | published in | FEBS Journal | Q1388041 |
P1476 | title | Beyond histones - the expanding roles of protein lysine methylation |
Q60921847 | A chemical biology toolbox to study protein methyltransferases and epigenetic signaling |
Q58789775 | Discerning evolutionary trends in post-translational modification and the effect of intrinsic disorder: Analysis of methylation, acetylation and ubiquitination sites in human proteins |
Q89768623 | Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors |
Q88241569 | Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification |
Q55261726 | Histone methylation in DNA repair and clinical practice: new findings during the past 5-years. |
Q99240240 | Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activities |
Q57009749 | Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks |
Q90477254 | Intriguing Origins of Protein Lysine Methylation: Influencing Cell Function Through Dynamic Methylation |
Q64101463 | Lysine methylation of transcription factors in cancer |
Q42778389 | Methylation of transcription factor YY2 regulates its transcriptional activity and cell proliferation. |
Q47328337 | Proteins and Proteoforms: New Separation Challenges. |
Q92460407 | Structural basis for the target specificity of actin histidine methyltransferase SETD3 |
Q89459237 | The clever strategies used by intracellular parasites to hijack host gene expression |
Q55423469 | The evaluation of anoxia responsive E2F DNA binding activity in the red eared slider turtle, Trachemys scripta elegans. |
Q92131608 | The lichen symbiosis re-viewed through the genomes of Cladonia grayi and its algal partner Asterochloris glomerata |
Q55511922 | The ribosome: A hot spot for the identification of new types of protein methyltransferases. |
Search more.